Investment Firm Increases Stake in Pediatrix Medical Group, Inc. (NYSE:MD)
Are you interested in investing in healthcare stocks? If so, you may want to take a closer look at Pediatrix Medical Group, Inc. (NYSE:MD). Oppenheimer Asset Management Inc. recently increased its position in the company by 4.5% in the first quarter, showing confidence in the stock’s potential.
But Oppenheimer Asset Management Inc. isn’t the only one bullish on Pediatrix Medical Group. Other hedge funds, such as Empowered Funds LLC, BNP Paribas Financial Markets, Principal Financial Group Inc., Invenomic Capital Management LP, and Aristides Capital LLC, have also made moves to increase their holdings in the company. In fact, hedge funds and other institutional investors now own 97.71% of Pediatrix Medical Group’s stock.
Wall Street analysts are also forecasting growth for Pediatrix Medical Group. Despite some recent rating changes, the consensus target price for the stock is $8.70, indicating potential upside.
However, it’s important to note that Pediatrix Medical Group’s stock has been trading down recently, with a 5.3% decrease. The company’s financials show positive earnings per share and revenue, but the stock has faced some challenges in the market.
Pediatrix Medical Group specializes in providing newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. With a focus on neonatal care services, the company plays a crucial role in the healthcare industry.
If you’re considering investing in Pediatrix Medical Group, it’s essential to stay informed about the latest news and analyst ratings. By signing up for MarketBeat.com’s daily email newsletter, you can receive updates on Pediatrix Medical Group and other related companies to make informed investment decisions.
Overall, Pediatrix Medical Group presents an interesting opportunity for investors looking to diversify their portfolio with a healthcare stock. Keep an eye on this company as it navigates the challenges and opportunities in the market.
